Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melanoma antigen family A, 10 pseudogene (ENSG00000270794, also known as LOC100420324 or MAGEA10P) is a non-protein-coding member of the MAGEA gene family, classified as a pseudogene. The MAGEA family is best known for encoding cancer/testis antigens involved in oncogenesis and immune response, but pseudogenes like MAGEA10P do not produce functional proteins[5]. Some MAGEA pseudogenes may act as regulatory RNAs, potentially influencing cancer development or serving as miRNA decoys, but they are not considered direct therapeutic targets and are not currently targeted by drugs or immunotherapies[5].\n\nThere are functional MAGEA genes (e.g., MAGEA4, MAGEA10) that are under study as immunotherapy targets in cancer, but ENSG00000270794 is not one of them, as it is explicitly annotated as a pseudogene and does not code for a protein[1][3][4][5]. The nomenclature and roles of MAGEA pseudogenes are an area of ongoing molecular research, and while some literature references roles in gene regulation, these are largely indirect and not associated with direct molecular targeting by therapeutics[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melanoma antigen family A, 10 pseudogene.